Halozyme Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/5/2026 | 1,771 | 0.0% | 26,310 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 1,912 | 0.0% | 26,072 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 1,431 | 0.0% | 27,512 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 1,805 | 0.0% | 28,288 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 1,352 | 0.0% | 28,276 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,609 | 0.0% | 28,105 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 1,487 | 0.0% | 28,407 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 1,199 | 0.0% | 29,464 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,086 | 0.0% | 29,389 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,118 | 0.0% | 29,258 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 1,056 | 0.0% | 29,264 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 1,146 | 0.0% | 29,998 | 3/31/2023 |
| 2022 Q4 | 2/21/2023 | 712 | 0.0% | 12,513 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 787 | 0.0% | 19,899 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 1,016 | 0.0% | 23,091 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 933 | 0.0% | 23,383 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 938 | 0.0% | 23,339 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 956 | 0.0% | 23,512 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 1,012 | 0.0% | 22,290 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 884 | 0.0% | 21,211 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,866 | 0.0% | 43,691 | 12/31/2020 |